Abstract |
Our data indicate that 1800 micrograms of per day is more effective than 1400 micrograms/day at the beginning of long-term management of severe asthma in adults whose symptoms are not controlled with the combination of 800 approximately 900 micrograms/day BDP and bronchodilators. Therapy with a higher dose (at least 1600 micrograms/day) of inhaled steroid is more useful and should be promptly began to treat severe asthma. Oral steroid therapy for long-term management should be introduced to mostly severe case after high dose inhaled BDP therapy reveals to be failure.
|
Authors | K Kudo |
Journal | Nihon rinsho. Japanese journal of clinical medicine
(Nihon Rinsho)
Vol. 54
Issue 11
Pg. 2993-7
(Nov 1996)
ISSN: 0047-1852 [Print] Japan |
PMID | 8950943
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Anti-Inflammatory Agents
- Beclomethasone
- Hydrocortisone
|
Topics |
- Administration, Inhalation
- Adult
- Anti-Inflammatory Agents
(administration & dosage, adverse effects)
- Asthma
(drug therapy, physiopathology)
- Beclomethasone
(administration & dosage, adverse effects)
- Chronic Disease
- Female
- Humans
- Hydrocortisone
(blood)
- Male
- Middle Aged
- Peak Expiratory Flow Rate
|